WHO recommends antibody treatment for COVID patients at high risk of hospital admissionDiseases, Conditions, Syndromes News

  • Post author:
  • Post published:September 23, 2021
  • Post category:Uncategorized

A treatment combining two antibodies (casirivimab and imdevimab) is recommended for two specific groups of patients with COVID-19 by a WHO Guideline Development Group (GDG) panel of international experts and patients in The BMJ today.